Amanote Research
Register
Sign In
A Novel Dual PI3Kα/mTOR Inhibitor PI-103 With High Antitumor Activity in Non-Small Cell Lung Cancer Cells
International Journal of Molecular Medicine
- Greece
doi 10.3892/ijmm_00000212
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Genetics
Date
June 4, 2009
Authors
Unknown
Publisher
Spandidos Publications
Related search
A Novel Imidazopyridine PI3K Inhibitor With Anticancer Activity in Non-Small Cell Lung Cancer Cells
Oncology Reports
Medicine
Cancer Research
Oncology
A Novel PI3K Inhibitor iMDK Suppresses Non-Small Cell Lung Cancer Cooperatively With a MEK Inhibitor
Experimental Cell Research
Cell Biology
Dual Inhibition of EGFR and mTOR Pathways in Small Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Antitumor Activity of Histone Deacetylase Inhibitors in Non-Small Cell Lung Cancer Cells: Development of a Molecular Predictive Model
Molecular Cancer Therapeutics
Cancer Research
Oncology
A Novel Small Inhibitor, LLL12, Targets STAT3 in Non‑small Cell Lung Cancer In�vitro and In�vivo
Oncology Letters
Cancer Research
Oncology
Telomerase Activity in Non-Small Cell Lung Cancer
Kardiochirurgia i Torakochirurgia Polska
Surgery
Cardiovascular Medicine
Cardiology
Epigenetic Modulation With HDAC Inhibitor CG200745 Induces Anti-Proliferation in Non-Small Cell Lung Cancer Cells
PLoS ONE
Multidisciplinary
Vorinostat Increases Carboplatin and Paclitaxel Activity in Non-Small Cell Lung Cancer Cells
International Journal of Cancer
Cancer Research
Oncology
OA12.02 Updated Antitumor Activity of Crizotinib in Patients With MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary